Article
Pharmacological inhibitors of c-KIT block mutant c-KIT mediated migration of melanocytes and melanoma cells in vitro and in vivo.
Oncotarget - 19 Jul 2016
Posch Christian, Moslehi Homayoun, Sanlorenzo Martina, Green Gary, Vujic Igor, Panzer-Grümayer Renate, Rappersberger Klemens, Ortiz-Urda Susana
Abstract excerpt
Mutations in the receptor tyrosine kinase c-KIT (KIT) are frequent oncogenic alterations in melanoma and are predominantly detected in tumors of acral, mucosal, and chronically sun-damaged skin. Research indicates that melanocytes with aberrant KIT signaling can be found in the distant periphery of the primary tumor; However, it is hitherto unknown whether KIT might confer a migratory advantage, thereby enabling...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
